Tahitian Noni International, Inc.

Morinda, Inc.

Other

Brett Justin West

Afa Kehaati Palu

Claude Jarakae Jensen

Stephen P Story

Chen Su

Bing-Nan Zhou

Robert Ogden

Shixin Deng

Scott Gerson

Claude Jarake Jensen

John P Gardner

Jeffrey A Wasden

Mian Ying Wang

Johannes Joseph Westendorf

Jeffery A Wasden

Shixin Dong

Embodiments of the invention relate to fortified food and dietary supplement products which may be administered to produce desirable physiological improvement. In particular, embodiments of the invention relates to the administration of products enhanced withand iridoids.

[object Object]

Fortified food and dietary supplement products may be administered to produce desirable physiological improvement. In particular, embodiments of the invention relates to the administration of products enhanced with plant products and iridoids. A study was performed to evaluate the iridoid content, as well as the in vitro and in vivo bioactivities, of a beverage containing noni fruit, Cornelian cherries, and olive leaf extract. The major iridoids present were identified as asperulosidic acid, deacetylasperulosidic acid, oleuropein, morroniside, loganic acid, and loganin In the 2,2-Diphenylpicrylhydrazyl (DPPH) radical scavenging assay, remarkably high in vitro antioxidant activity was observed, with an ICof 3.8 &#x3bc;L/mL. In vivo bioactivities were evaluated in type 2 diabetic Sprague Dawley rats. In a dose-dependent manner, the composition reduced abnormal weight gain, blood glucose levels, and serum advanced glycation end products (AGEs), as well as improved immunity via increased T cell counts and CD4+/CD8ratios.

The present invention relates to methods and formulations directed to the management of Cathepsin G, Cathepsin S, Cathepsin B, Cathepsin L, Butyryl Cholinesterase, Peptidase HIV-1, and NF-kB enzymes comprising the administration of processedbased formulations.

This invention relates to a method and composition for providing in various health benefits by administering various bioactive compounds derived from the plantto individuals. This invention relates to using one or more of the following: Noni Leaf Extract; Noni Leaf Juice; and/or Roast Leaf More particularly this invention relates to administering one or more of the following: Pyro-phorbide a, Pheophorbide a, Purpin 7, and/or Pheophorbide all which may be derived from Noni leaf extract, Noni leaf juice, and/or Roast leaf Moreover, the foregoing formulations result in alleviating pain and inflammation.

Implementation is directed to selectively inhibiting estrogen production and providing estrogenic effects in a human body. A dietary supplement includes a processedproduct that is used to inhibit aromatase or aromatase enzymes that function to convert androgens to estrogens, inhibit receptors from binding with estrogen, and reduce and/or regulate estrogen production, as well as reduce the amount of estrogen produced within the body and regulating such production. The dietary supplement further provides estrogenic effects. The present invention methods and compositions effectively function to treat estrogen-dependent cancers, and particularly inhibit, destroy, and reverse the effects of of estrogen-dependent cancerous tumors through the introduction into the body (e.g. ingesting) a safe, pre-determined dosage of a naturaceutical composition formulated with or comprising one or more processedproducts for a safe, pre-determined duration.

Selectively inhibiting estrogen production and providing estrogenic effects in the human body

This invention relates to a method and composition for providing in various health benefits by administering various bioactive compounds derived from the plantto individuals. This invention relates to using one or more of the following: Noni Leaf Extract; Noni Leaf Juice; and/or Roast Leaf. More particularly this invention relates to administering one or more of the following: Pyro-phorbide a, Pheophorbide a, Purpin 7, and/or Pheophorbide all which may be derived from Noni leaf extract, Noni leaf juice, and/or Roast leaf. Moreover, the foregoing formulations result in alleviating pain and inflammation.

The present invention features a formulation from the Indian mulberry plant () comprisingfruit juice,oil, quercetin,puree juice anddietary fiber treating Candidiasis.

The present invention features a novel use of processed ingredients from the Indian mulberry plant, and particularly a novel use of one or more processed-based naturaceutical formulations comprising one or more of a processedfruit juice, puree juice, oil or oil extract, dietary fiber, alcohol extract, etc., for inhibiting and preventing the overgrowth offungus and for treating Candidiasis and its associated symptoms.

Method and formulation for treating candidiasis using morinda citrifolia

The use of an improved method for freeze concentration is disclosed. The method provides for first freezing components of a pulpy slurry of. More dilute components are extracted after the initial freezing. A secondary freezing process at a lower temperature allows more concentrated portions of aslurry to be removed. Flavor and therapeutic oils remain in the resulting concentrate for improved flavor and health benefits.

Freeze concentration process

A viewer discretion television program control system including devices and methods for controlling access to television viewing, especially by children. It includes provision for storing suitability ratings for each program receivable by a television set, allocation of personal identification numbers to each of a plurality of potential viewers (e.g., children), and individual allocations of permissible viewing time and program content, all under the control of a local authority such as a parent or guardian.

Growing community of inventors

Cedar Hills, UT, United States of America

Brett Justin West